Skip to search formSkip to main contentSkip to account menu

Bonefos

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
496 Background: We evaluated the role of bisphosphonates in conjunction with sorafenib in improving progression-free survival… 
2008
2008
Objective: To evaluate the clinical efficacy and safety of Ibandronate and Bonefos for non-small cell lung cancer (NSCLC) with… 
2006
2006
TRANSPLANTATION (KT). I.Rekina~ M.Mirovski, S.Rodionova*, N.Tomilina, Inst. of Transplantology and Artificial Organs, Inst. of… 
Review
2004
Review
2004
Bisphosphonate therapy has become a standard of care for patients with malignant bone disease. In addition, preclinical and… 
2003
2003
OBJECTIVE To compare the therapeutic effects of single- and combined-modality therapy on bone metastasis of non-small-cell lung… 
2002
2002
BACKGROUND To evaluate the effect of ⁸⁹SrCl₂ and/or Bonefos in the treatment of bone metastasis from pulmonary carcinoma… 
Review
2002
Review
2002
The tolerance of Bonefos was assessed by means of a questionnaire completed by 87 (76.3%) of 114 addressed patients with multiple… 
2000
2000
AIM To evaluate the effect of 153 Sm EDTMP or/and bonefos in the treatment of 60 cases of metastatic bone cancer. METHODS All… 
1993
1993
A clinical trial of a new drug bonefos (Leiras, Finland) in 13 patients with multiple myeloma confirmed its potent analgetic…